Tag: life sciences
R.I. Hospital study investigates if drug can slow, improve Alzheimer’s symptoms
PROVIDENCE – Rhode Island Hospital researchers are seeking subjects for a Phase 2 study into whether an investigational drug, Troriluzole, a new version of...
Seewoester replaces Bush as Amgen VP of site operations for R.I.,...
PROVIDENCE – Tia Bush has moved on from her role as Amgen Inc.’s vice president of site operations, Rhode Island and Woburn, Mass., to...
Rubius reports $26.4M loss for Q3
PROVIDENCE – Cambridge, Mass.-headquartered Rubius Therapeutics Inc. announced a $26.4 million net loss for the third quarter of 2018 Tuesday. The company reported an...
PBN on WJAR-TV, Nov. 12, 2018
Despite false starts, transformation of Jewelry District taking shape.
Every week, PBN Editor Mark S. Murphy appears on WJAR-TV NBC 10’s Coffee Break to discuss...
Finding purpose, passion, people and finally place here in Rhode Island
Patrice M. Milos | Medley Genomics Inc. co-founder, president and CEO
Over the course of my 25-year life sciences career, I have been fortunate to...
The Miriam Hospital receives $9.4M grant to study antibiotic resistance
PROVIDENCE – The Miriam Hospital has received a five-year, $9.4 million grant from the National Institutes of Health to create an NIH Center for...
R.I. Hospital receives $11.8M federal grant to establish opioid research center
PROVIDENCE – Rhode Island Hospital has received an $11.8 million federal grant to address the opioid epidemic by establishing the Center of Biomedical Research...
Rubius Therapeutics enters agreement to buy former Alexion site in Smithfield
SMITHFIELD – Rubius Therapeutics Inc., the Cambridge, Mass.-based company recently approved by the R.I. Commerce Corp. for up to $9 million in incentives to...
Tracy Schorner, 37
SENIOR MANAGER, MANUFACTURING – AMGEN RHODE ISLAND
Where do you see yourself professionally in 20 years? Hopefully doing something impactful, rewarding and challenging, though part...
BBJ: Rubius Therapeutics raises $241M in IPO, highest for biotech company...
PROVIDENCE – Cambridge, Mass.-based Rubius Therapeutics Inc. raised $241 million in its initial public offering Wednesday, the highest for a biotechnology company in Massachusetts...
- Featured Event -
